Skip to main content

Post-IPO Equity Biotechnology Companies

Explore 481 biotechnology startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
481
Total Funding
$1.8B
Avg Funding
$74.0M
Cities
20

Export 481 Post-IPO Equity Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
$6.1M
raised

Zelluna Immunotherapy is a privately owned Norwegian biopharmaceutical company.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Piscataway, United States
$226.0M
raised

Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Antonio, United States
$3.2M
raised

BioAffinity Technologies is a cancer diagnostics company that develops non-invasive, early-stage diagnostics to detect cancer and diseases.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Silver Spring, United States
$13.3M
raised

Elutia is a developer of customized tissue products intended to restore health and mobility to the greatest number of patients.

Jun 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$57.5M
raised

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Boston, United States
$57.5M
raised

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$57.5M
raised

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$57.5M
raised

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Omaha, United States
$11.0M
raised

Klotho Neurosciences develops disease modifying therapies for age-related cognitive and neurodegenerative disorders and cancer.

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ringwood, Australia
$20.9M
raised

Trajan is a biotech company that develops and commercializes technologies that enable analytical systems.

Jun 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Reykjavík, Iceland
$165.0M
raised

Alvotech is a biotechnology company that specializes in making biosimilars to create biologic medicines.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$235.5M
raised

Zentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$50.0M
raised

Mereo is a new UK-based speciality biopharmaceutical company.

Jun 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Brisbane, Australia
$3.5M
raised

Microba Life Sciences is a precision microbiome science company powering medical innovation to transform human health.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$429K
raised

Avicanna is a biopharmaceutical company that focuses on the development of the medical cannabis space.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Mölndal, Sweden
$564K
raised

Pioneering advanced cancer diagnostics and regenerative medicine treatments.

Jun 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boulder, United States
$460.0M
raised

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$75.0M
raised

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Markham, Canada
$2.5M
raised

Edesa develops treatments for dermatological and anorectal diseases. Edesa merged with Stellar Biotechnologies in 2019.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Charlottesville, United States
$32.0M
raised

Adial Pharmaceuticals develops prescription medications for addiction and related disorders.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Austin, United States
$75.0M
raised

Shattuck Labs is a biotechnology company that provides novel class biologic medicines for the treatment of cancer and autoimmune disease.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Heidelberg, Germany
$50.0M
raised

VERAXA Biotech specializes in ADC development combining cutting-edge solutions for targeted antibody discovery and bioconjugation.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Oslo, Norway
$31.5M
raised

Targovax develops active immunotherapy in the form of cancer vaccines for application in post-operation treatments.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$25.0M
raised

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Zug, Switzerland
$132.3M
raised

Pharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients.

May 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 126 to 150 of 481 companies

Ready to Connect with Post-IPO Equity Biotechnology Startups?

Get verified founder emails, funding details, and company data for 481 post-ipo equity biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked